This is a working overview of animal model, written for readers who want more than a one-paragraph summary but less than a textbook.
This page was last updated on 2026-01-01 and is reviewed periodically as new material appears.
Proposed mechanisms include interaction with the nitric oxide system, modulation of growth factor signaling, and effects on blood vessel formation. None of these has been established as the primary mode of action, and some proposed pathways rest on indirect measurements. Whether the reported effects depend on a specific receptor has not been determined. Stability in gastric acid, unusual for a peptide of this size, is also reported in animal work, but the reason for it is not firmly established.
Published studies on BPC-157 are dominated by animal models. Commonly used endpoints include healing of surgically induced lesions in the stomach, tendon-to-bone attachment after transection, and recovery from experimentally induced vascular or intestinal damage. Many of these reports come from a small number of research groups, and the peptide is often described as acting across a wide range of tissue types. That breadth is itself a point of discussion, since one molecule influencing many unrelated systems is unusual.
Common synonyms in catalogs include pentadecapeptide BPC 157, BPC157, and the full sequence name. A CAS registry number in the 137525-51-0 range is frequently listed, though the assignment should be verified against the supplier certificate of analysis. The name itself is not a pharmacopoeial designation, and there is no standardized international nonproprietary name. Distinguishing genuine material from related fragments generally requires mass spectrometry, since several truncated sequences share similar chromatographic behavior.
BPC-157 is a synthetic pentadecapeptide whose sequence is commonly given as Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. It is described in the literature as a fragment of a larger protein found in human gastric juice, referred to as body protection compound. The peptide was first characterized in the early 1990s by a research group in Zagreb, Croatia. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
Supplied material is typically a lyophilized white to off-white powder. The peptide is freely soluble in water and in common aqueous buffers, which allows it to be handled as a stock solution. Because the sequence contains no cysteine, disulfide cross-linking is not a route of degradation. The absence of aromatic residues means ultraviolet absorbance at 280 nm is minimal, so quantification usually relies on peptide bond absorbance near 214 nm or on amino acid analysis.
| Property | Value | Notes |
|---|---|---|
| Study species | Rodents, mainly rats | Most reports use surgically induced injury models |
| Typical administration route | Subcutaneous or intraperitoneal injection | Routes differ between reports, which complicates comparison |
| Human trial evidence | Limited, small-scale reports | No large randomized trial in indexed journals |
| Reported outcome categories | Mucosal healing, tendon repair, vascular recovery | Endpoints are not standardized across studies |
| Mechanism status | Not established | Proposed pathways lack direct confirmation |
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
The sequence places several glycine and proline residues near the middle, which may influence how the chain folds in solution. The peptide is linear rather than cyclic, and it carries no disulfide bridges. Commercial material is commonly supplied as the acetate salt, although the free base and other counterion forms also appear. Because the term BPC-157 refers to a specific sequence, samples with slight sequence variants are chemically different substances. Published work generally treats the fifteen-residue sequence as the defining structure.
Physical descriptions in supplier documents and papers usually list the compound as a white to off-white powder. It dissolves readily in water and in common aqueous buffers, and solutions are often prepared fresh before an experiment. Molecular mass near 1419 daltons helps verify identity during mass spectrometry. The powder is somewhat hygroscopic, so moisture exposure can alter the measured mass of a sample. Purity is typically reported as a percentage from chromatographic analysis.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence is GEPPPGKPADDAGLV. Its name derives from the phrase body protection compound, a term applied to a protein fraction originally detected in human gastric juice. The short peptide is not that full protein; it corresponds to a stable fragment of the larger molecule. Researchers frequently describe it as a pentadecapeptide because it contains exactly fifteen residues. Its neutral molecular mass is approximately 1419 daltons.
BPC-157 is commonly supplied as a lyophilized powder, a freeze-dried solid that is reconstituted before use in laboratory work. As a short peptide, it dissolves readily in water and in aqueous buffer solutions, and stock solutions are typically prepared in water or a mild buffer. The chain contains several proline and acidic residues, which influence how it behaves in solution. Because the solid can take up moisture, weighing and handling are usually performed under low-humidity conditions. Its solubility class is described as freely soluble in water rather than requiring an organic solvent.
Dry powder is generally stored at low temperature, with minus twenty degrees Celsius or colder advised for extended retention. Reconstituted solutions are less stable than the solid form and are normally kept cold and shielded from repeated freeze-thaw cycles. Light exposure is avoided because some peptides degrade under ultraviolet radiation. The exact rate of degradation depends on concentration, pH, and the presence of salts, so a single shelf life does not apply to every preparation. Reported stability figures should be read as indicative of typical handling rather than as universal constants.
== Success rate == Candidates for a new drug to treat a disease might, theoretically, include from 5,000 to 10,000 chemical compounds. On average about 250 of these show sufficient promise for further evaluation using laboratory tests, mice and other test animals. Typically, about ten of these qualify for tests on humans. A study conducted by the Tufts Center for the Study of Drug Development covering the 1980s and 1990s found that only 21.5 percent of drugs that started Phase I trials were eventually approved for marketing. In the time period of 2006 to 2015, the success rate was 9.6%. The high failure rates associated with pharmaceutical development are referred to as the "attrition rate" problem. Careful decision making during drug development is essential to avoid costly failures. In many cases, intelligent programme and clinical trial design can prevent false negative results. Well-designed, dose-finding studies and comparisons against both a placebo and a gold-standard treatment arm play a major role in achieving reliable data.
=== Neutrons === After the discovery of the neutron by James Chadwick in 1932, the ultimate root cause for the existence of isotopes was clarified, that is, the nuclei of different isotopes for a given element have different numbers of neutrons, albeit having the same number of protons.
=== Stone India === Jupiter Wagons Ltd was selected as the successful resolution applicant by the Committee of Creditors of Stone India Ltd, which used to supply electrical engineering products to Indian Railways such as Pantograph. Both JWL and Stone India being engaged in the same line of activity, the acquisition of Stone India by JWL was thereby slated to provide natural synergy to the company.
Other religions in India (and population in the 2011 census) are Sarnaism (4.96 million) and Gondi-Koyapunem (1.03 million) and Sari dharma (510,000). In 1951—India's first postcolonial census—the percentage breakdown of India's religions was: Hindu (84.1%), Muslims (9.8%), Christians (2.3%), Sikhs (1.9%), Buddhists (0.7%) and Jains (0.5%); sixty years later, in India's last census (2011), the percentages were: Hindus (79.8%), Muslims (14.2%), Christians (2.3%), Sikhs (1.7%), Buddhists (0.7%) and Jains (0.4%) In absolute numbers, during the period 1951–2011, India's religious groups grew in the following manner: Hindus (304 million to 966 million), Muslims (35 million to 172 million), Christians (8.3 million to 28 million), Sikhs (6.82 million to 20.83 million), Buddhists (2.67 million to 8.44 million) and Jains (1.66 million to 4.45 million). In the decade 1951–1961, the population growth by religions was: Hindus (20.7%), Muslims (32.7%), Christians (29%), Sikhs (10.3%), Buddhists (5.9%), Jains (3.7%); in the decade 2001–2011, the growth was: Hindus (16.7%), Muslims (24.7%), Christians (15.7%), Sikhs (16.1%), Buddhists (4.8%), and Jains (2.2%). All religions have registered declining growth rates. Birth rates, population growth, and access to education influence how communities mobilise politically to preserve their places of worship, to manage charitable trusts, and to protect their family laws. Differences in states' laws, especially those prohibiting religious conversion—usually from Hinduism to other faiths—colour the daily lives of minority communities.
== See also == Enterprise Architecture framework Enterprise Collaboration Architecture Enterprise Modelling Methodology/Open Distributed Processing (EMM/ODP) Reference model Triune Continuum Paradigm View model ISO/IEC JTC 1/SC 7
Sources: en.wikipedia.org
The split and pool synthesis (S&P synthesis) differs from traditional synthetic methods. The important novelty is the use of compound mixtures in the process. This is the reason of its unprecedentedly high productivity. Using the method one single chemist can make more compounds in a week than all chemists produced in the whole history of chemistry. The S&P synthesis is applied in a stepwise manner by repeating three operations in each step of the process:
== Mechanical characteristics == While many uses of ivory are purely ornamental in nature, it often must be carved and manipulated into different shapes to achieve the desired form. Other applications, such as ivory piano keys, introduce repeated wear and surface handling of the material. It is therefore essential to consider the mechanical properties of ivory when designing alternatives. Elephant tusks are the animal's incisors, so the composition of ivory is unsurprisingly similar to that of teeth in several other mammals. It is composed of dentine, a biomineral composite constructed from collagen fibers mineralized with hydroxyapatite. This composite lends ivory the impressive mechanical properties—high stiffness, strength, hardness, and toughness—required for its use in the animal's day-to-day activities. Ivory has a measured hardness of 35 on the Vickers scale, exceeding that of bone. It also has a flexural modulus of 14 GPa, a flexural strength of 378 MPa a fracture toughness of 2.05 MPam1/2. These measured values indicate that ivory mechanically outperforms most of its most common alternatives, including celluloid plastic and polyethylene terephthalate. Ivory's mechanical properties result from the microstructure of the dentine tissue. It is thought that the structural arrangement of mineralized collagen fibers could contribute to the checkerboard-like Schreger pattern observed in polished ivory samples. This is often used as an attribute in ivory identification.
==== H1 receptor ==== Mirtazapine is a very strong H1 receptor antagonist and, as a result, it can cause powerful sedative and hypnotic effects. A single 15 mg dose of mirtazapine to healthy volunteers has been found to result in over 80% occupancy of the H1 receptor and to induce intense sleepiness. After a short period of chronic treatment, however, the H1 receptor tends to sensitize and the antihistamine effects become more tolerable. Many patients may also dose at night to avoid the effects, and this appears to be an effective strategy for combating them. Blockade of the H1 receptor may improve pre-existing allergies, pruritus, nausea, and insomnia in affected individuals. It may also contribute to weight gain, however. In contrast to the H1 receptor, mirtazapine has only low affinity for the muscarinic acetylcholine receptors, although anticholinergic side effects like dry mouth, constipation, and mydriasis are still sometimes seen in clinical practice.
In 2015, Duterte made homophobic remarks about United States ambassador Philipp Goldberg after Secretary of State John Kerry visited the Philippines. Duterte's record on human rights and his long history of comments that have widely been considered to be offensive, provocative, threatening, and undiplomatic have received sharp international criticism. He has been portrayed by his critics in the media as having a "dirty mouth". He had, however, promised to behave in a "prim and proper" manner on the national and international stage once he was to be inaugurated as president, to the point that, "almost, I would become holy." Throughout his presidency, Duterte has made controversial comments about rape, human rights, his views on media killings, and has used slurs; he has also made controversial statements to international leaders and institutions. He has also repeatedly criticized the Catholic Church which has expressed alarm over deaths linked to the war on drugs. Human Rights Watch (HRW) called the first year of Duterte in office a "human rights calamity". HRW estimates that there have been 7,000 deaths from the day Duterte first took office to January 2017. The Duterte administration suspended the drug war in February 2017 in an effort to cleanse the police ranks of supposed corruption, also halting the disclosure of figures on deaths related to drug arrests and raids. In March 2017, HRW released a special investigation and report on the state of police related shooting, titled "License To Kill".
=== Brain === Broad generalizations are often made in popular psychology about certain brain functions being lateralized, or more predominant in one hemisphere than the other. These claims are often inaccurate or overstated. The human brain, particularly the prefrontal cortex, does not reach "full maturity" or "full development" at any particular age (e.g. 16, 18, 21, 25, 30). Changes in structure and myelination of gray matter are recorded to continue with relative consistency all throughout life including until death. Different mental abilities peak earlier or later in life. Humans do not generate all of the brain cells they will ever have by the age of two years. Although this belief was held by medical experts until 1998, it is now understood that new neurons can be created after infancy in some parts of the brain into late adulthood. People do not use only 10% of their brains. While it is true that a small minority of neurons in the brain are actively firing at any one time, a healthy human will normally use most of their brain over the course of a day, and the inactive neurons are important as well. The idea that activating 100% of the brain would allow someone to achieve their maximum potential and/or gain various psychic abilities is common in folklore and fiction, but doing so in real life would likely result in a fatal seizure. This misconception was attributed to late 19th century leading thinker William James, who apparently used the expression only metaphorically.
Sources: en.wikipedia.org
In madhyamaka philosophy, to say that an object dependently originated is synonymous with saying that it is "empty" (shunya). This is directly stated by Nāgārjuna in his Mūlamadhyamakakārikā (MMK): Whatever arises dependently, is explained as empty. Thus dependent attribution, is the middle way. Since there is nothing whatever, that is not dependently existent. For that reason, there is nothing whatsoever that is not empty. – MMK, Ch. 24.18–19According to Nāgārjuna, all phenomena (dharmas) are empty of svabhāva (variously translated as essence, intrinsic nature, inherent existence, and own being) which refers to a self-sustaining, causally independent and permanent identity. Nāgārjuna's philosophical works analyze all phenomena in order to show that nothing at all can exist independently, and yet, they are also not non-existent since they exist conventionally, i.e. as empty dependent arisings. In the very first (dedicatory) verse of the MMK, dependent origination is also described apophatically through "the eight negations" as follows "there is neither cessation nor origination, neither annihilation nor the eternal, neither singularity nor plurality, neither the coming nor the going of any dharma, for the purpose of nirvāṇa characterized by the auspicious cessation of hypostatization [prapañca]." The first chapter of the MMK focuses on the general idea of causation and attempts to show how it is a process that is empty of any essence.
Larry Overman and coworkers make use of the Stille-carbonylative cross-coupling in their 20-step enantioselective total synthesis of strychnine. The added carbonyl is later converted to a terminal alkene via a Wittig reaction, allowing for the key tertiary nitrogen and the pentacyclic core to be formed via an aza-Cope-Mannich reaction.
Radon is a chemical element; it has symbol Rn and atomic number 86. It is a radioactive noble gas and is colorless and odorless. Of the three naturally occurring radon isotopes, only 222Rn has a sufficiently long half-life (3.825 days) for it to be released from the soil and rock where it is generated. Radon isotopes are the immediate decay products of radium isotopes. The instability of 222Rn, its most stable isotope, makes radon one of the rarest elements. Radon will be present on Earth for several billion more years despite its short half-life, because it is constantly being produced as a step in the decay chains of 238U and 232Th, both of which are abundant radioactive nuclides with half-lives of at least several billion years. The decay of radon produces many other short-lived nuclides, known as "radon daughters", ending at stable isotopes of lead. 222Rn occurs in significant quantities as a step in the normal radioactive decay chain of 238U, also known as the uranium series, which slowly decays into a variety of radioactive nuclides and eventually decays into stable 206Pb. 220Rn occurs in minute quantities as an intermediate step in the decay chain of 232Th, also known as the thorium series, which eventually decays into stable 208Pb. Radon was discovered in 1899 by Ernest Rutherford and Robert B. Owens at McGill University in Montreal, and was the fifth radioactive element to be discovered.
=== Research === G-CSF when given early after exposure to radiation may improve white blood cell counts, and is stockpiled for use in radiation incidents. Mesoblast planned in 2004 to use G-CSF to treat heart degeneration by injecting it into the blood-stream, plus SDF (stromal cell-derived factor) directly to the heart. G-CSF has been shown to reduce inflammation, reduce amyloid beta burden, and reverse cognitive impairment in a mouse model of Alzheimer's disease. Due to its neuroprotective properties, G-CSF is currently under investigation for cerebral ischemia in a clinical phase IIb and several clinical pilot studies are published for other neurological disease such as amyotrophic lateral sclerosis A combination of human G-CSF and cord blood cells has been shown to reduce impairment from chronic traumatic brain injury in rats.
Sources: en.wikipedia.org
It is not authorized as a medicine in the United States or the European Union. Regulatory treatment varies by jurisdiction, and in several places it is handled as a research chemical. Therapeutic claims are not supported by large human trials.
Human evidence is sparse and comes from small reports rather than large trials. Sample sizes are generally too small to support firm conclusions. The published record does not contain an independently replicated randomized trial.
Several pathways have been proposed, including effects on nitric oxide signaling and vessel formation. Direct confirmation of a primary molecular target is lacking. Some findings rest on indirect measurements, which leaves the mechanism an open question.
It is a synthetic peptide built from fifteen amino acids, with a mass of roughly 1419 daltons. The sequence is reported to match a fragment of a protein present in human gastric juice. It is not a naturally circulating hormone.